Tokyo, Feb. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060066) titled 'A Study Evaluating Effectiveness and Treatment Patterns of Mavacamten In Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Cibenzoline in Japan' on Feb. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Bristol-Myers Squibb K.K.
Condition:
Condition - Hypertrophic obstructive cardiomyopathy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To assess the effectiveness of a 16-week course of mavacamten treatment in reducing the resting or Valsalva left ventricular outflow tract (LVOT) peak gradient whichever used to judge the initiation of mava...